Add BrightSurf on Google Email

Science News for May 20, 2012


UW study: Sleep apnea associated with higher mortality from cancer

A new study published in the American Journal of Respiratory and Critical Care Medicine found a significant association between sleep-disordered breathing (SDB) and increased risk of cancer mortality. Patients with severe SDB had a nearly five times higher incidence of cancer deaths compared to those without the disorder.

SourceUniversity of Wisconsin-Madison·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMay 20, 2012

Supercharged safflower

A new 'super-high' oleic safflower has been developed by CSIRO, with the potential to provide over 100,000 hectares of sustainable plant oils. The oil contains over 90% of valuable oleic acid, making it suitable for industrial chemical production and direct use in lubricants.

First, do no harm: Study finds danger in standard treatment for a serious lung disease

A new study reveals that a combination of three drugs used to treat idiopathic pulmonary fibrosis can lead to increased risk of death and hospitalization. The researchers found no improvement in lung function or slowing of disease progression with the treatment, highlighting the importance of rigorous testing methods.

SourceMichigan Medicine - University of Michigan·JournalNew England Journal of Medicine·DateMay 20, 2012

New approach to 'spell checking' gene sequences

A new software tool called Acacia has been developed to correct errors in DNA sequencing, allowing biologists to accurately interpret genetic information. The tool, created by CSIRO PhD student Lauren Bragg, uses statistical theory to analyze code for DNA bases and improve accuracy.

SourceCSIRO Australia·JournalNature Methods·DateMay 20, 2012

Novel discovery by NUS scientists paves the way for more effective treatment of cancers

Researchers from NUS have discovered how a drug-lead compound named BPTES can deprive cancer cells of energy and stop them from growing into a tumour. Building on these findings, they also derived positive results for a novel dual-drug treatment regime that kills kidney and breast cancer cells more effectively.

SourceNational University of Singapore·JournalProceedings of the National Academy of Sciences·DateMay 20, 2012